Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-013526
Filing Date
2021-03-25
Accepted
2021-03-25 18:30:16
Documents
1
Period of Report
2020-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 2546
  Complete submission text file 0000899243-21-013526.txt   3875
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Skovronsky Daniel (Reporting) CIK: 0001741474 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26642 | Film No.: 21773925